Iofina Plc. CEO Thomas Becker joined Steve Darling from Proactive to discuss the company’s latest financial performance, highlighting a series of record-breaking results in its audited full-year report for the period ending December 2025. Becker outlined that the company delivered another standout year, reporting revenue of $66.5 million—an increase of 22% year-over-year—marking its eighth consecutive year of sustained growth. He attributed much of this momentum to strong operational performance across its core iodine business, with crystalline iodine sales surging by 42%, while iodine derivatives sales posted a solid 5% increase. This top-line growth translated into significant profitability gains. Gross profit rose 36% to $18.0 million, supported by improved efficiencies and favourable pricing. Adjusted EBITDA saw an even sharper rise of 56%, reflecting strong operational leverage, while operating profit climbed 74%. Profit before tax reached $8.4 million, representing a 75% in...